Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

The development of mRNA vaccines represented a significant achievement in response to the global health crisis during the SARS-CoV-2 pandemic. Evaluating vaccine efficacy entails identifying different anti-SARS-CoV-2 antibodies, such as total antibodies against the Receptor Binding Domain (RBD) of t...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Roberto Alonso, Sergio Gil-Manso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, Patricia Muñoz, Marjorie Pion, the Gregorio Marañón Microbiology-ID COVID-19 Study Group
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-02-01
Serija:	Frontiers in Immunology
Teme:	SARS-CoV-2 anti-RBD IgG neutralizing antibodies breakthrough infection humoral immunity
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1341313/full
Oznake:	Označite Brez oznak, prvi označite!